These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21565828)

  • 1. IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration.
    Jaquish DV; Yu PT; Shields DJ; French RP; Maruyama KP; Niessen S; Hoover H; A Cheresh D; Cravatt B; Lowy AM
    Carcinogenesis; 2011 Aug; 32(8):1151-6. PubMed ID: 21565828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The RON-receptor regulates pancreatic cancer cell migration through phosphorylation-dependent breakdown of the hemidesmosome.
    Yu PT; Babicky M; Jaquish D; French R; Marayuma K; Mose E; Niessen S; Hoover H; Shields D; Cheresh D; Cravatt BF; Lowy AM
    Int J Cancer; 2012 Oct; 131(8):1744-54. PubMed ID: 22275185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAK and IGF-IR interact to provide survival signals in human pancreatic adenocarcinoma cells.
    Liu W; Bloom DA; Cance WG; Kurenova EV; Golubovskaya VM; Hochwald SN
    Carcinogenesis; 2008 Jun; 29(6):1096-107. PubMed ID: 18263593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ron knockdown and Ron monoclonal antibody IMC-RON8 sensitize pancreatic cancer to histone deacetylase inhibitors (HDACi).
    Zou Y; Howell GM; Humphrey LE; Wang J; Brattain MG
    PLoS One; 2013; 8(7):e69992. PubMed ID: 23922886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
    Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
    Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting insulin-like growth factor 1 receptor inhibits pancreatic cancer growth and metastasis.
    Subramani R; Lopez-Valdez R; Arumugam A; Nandy S; Boopalan T; Lakshmanaswamy R
    PLoS One; 2014; 9(5):e97016. PubMed ID: 24809702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel protein isoform of the RON tyrosine kinase receptor transforms human pancreatic duct epithelial cells.
    Chakedis J; French R; Babicky M; Jaquish D; Howard H; Mose E; Lam R; Holman P; Miyamoto J; Walterscheid Z; Lowy AM
    Oncogene; 2016 Jun; 35(25):3249-59. PubMed ID: 26477314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of RON receptor signaling promotes apoptosis and gemcitabine sensitivity in pancreatic cancers.
    Logan-Collins J; Thomas RM; Yu P; Jaquish D; Mose E; French R; Stuart W; McClaine R; Aronow B; Hoffman RM; Waltz SE; Lowy AM
    Cancer Res; 2010 Feb; 70(3):1130-40. PubMed ID: 20103639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The RON receptor tyrosine kinase in pancreatic cancer pathogenesis and its potential implications for future targeted therapies.
    Kang CM; Babicky ML; Lowy AM
    Pancreas; 2014 Mar; 43(2):183-9. PubMed ID: 24518495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic lethality screens reveal RPS6 and MST1R as modifiers of insulin-like growth factor-1 receptor inhibitor activity in childhood sarcomas.
    Potratz JC; Saunders DN; Wai DH; Ng TL; McKinney SE; Carboni JM; Gottardis MM; Triche TJ; Jürgens H; Pollak MN; Aparicio SA; Sorensen PH
    Cancer Res; 2010 Nov; 70(21):8770-81. PubMed ID: 20959493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of short-form RON as a novel intrinsic resistance mechanism for anti-MET therapy in MET-positive gastric cancer.
    Wu Z; Zhang Z; Ge X; Lin Y; Dai C; Chang J; Liu X; Geng R; Wang C; Chen H; Sun M; Guo W; Li J
    Oncotarget; 2015 Dec; 6(38):40519-34. PubMed ID: 26528757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma.
    Vanderwerff BR; Church KJ; Kawas LH; Harding JW
    Cytokine; 2019 Nov; 123():154762. PubMed ID: 31254927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement component 1, q subcomponent binding protein (C1QBP) in lipid rafts mediates hepatic metastasis of pancreatic cancer by regulating IGF-1/IGF-1R signaling.
    Shi H; Fang W; Liu M; Fu D
    Int J Cancer; 2017 Oct; 141(7):1389-1401. PubMed ID: 28608366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant expression and activation of insulin-like growth factor-1 receptor (IGF-1R) are mediated by an induction of IGF-1R promoter activity and stabilization of IGF-1R mRNA and contributes to growth factor independence and increased survival of the pancreatic cancer cell line MIA PaCa-2.
    Nair PN; De Armond DT; Adamo ML; Strodel WE; Freeman JW
    Oncogene; 2001 Dec; 20(57):8203-14. PubMed ID: 11781836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RON receptor tyrosine kinase mediates oncogenic phenotypes in pancreatic cancer cells and is increasingly expressed during pancreatic cancer progression.
    Thomas RM; Toney K; Fenoglio-Preiser C; Revelo-Penafiel MP; Hingorani SR; Tuveson DA; Waltz SE; Lowy AM
    Cancer Res; 2007 Jul; 67(13):6075-82. PubMed ID: 17616662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel nuclear localization and potential function of insulin-like growth factor-1 receptor/insulin receptor hybrid in corneal epithelial cells.
    Wu YC; Zhu M; Robertson DM
    PLoS One; 2012; 7(8):e42483. PubMed ID: 22879999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective recruitment of G protein-coupled receptor kinases (GRKs) controls signaling of the insulin-like growth factor 1 receptor.
    Zheng H; Worrall C; Shen H; Issad T; Seregard S; Girnita A; Girnita L
    Proc Natl Acad Sci U S A; 2012 May; 109(18):7055-60. PubMed ID: 22509025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal protein S6 kinase (RSK)-2 as a central effector molecule in RON receptor tyrosine kinase mediated epithelial to mesenchymal transition induced by macrophage-stimulating protein.
    Ma Q; Guin S; Padhye SS; Zhou YQ; Zhang RW; Wang MH
    Mol Cancer; 2011 May; 10():66. PubMed ID: 21619683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas.
    Yu L; Saile K; Swartz CD; He H; Zheng X; Kissling GE; Di X; Lucas S; Robboy SJ; Dixon D
    Mol Med; 2008; 14(5-6):264-75. PubMed ID: 18231572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA; Lee KH; Lee DH; Lee JK; Lim SC; Joo YE; Chung IJ; Noh MG; Yoon TM
    Int J Oncol; 2019 Aug; 55(2):513-526. PubMed ID: 31268163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.